Regulatory Oversight and Compliance

>

Latest News

Cambridge, MA, USA - June 29, 2022: Moderna logo is seen at the entrance to its headquarters in Cambridge, Massachusetts. Moderna, Inc., is an American pharmaceutical and biotechnology company. | Image Credit: © Tada Images - stock.adobe.com
FDA Approves New Moderna COVID-19 Vaccine mNEXSPIKE

June 2nd 2025

A Phase III trial demonstrated mNEXSPIKE’s non-inferior efficacy compared with Moderna’s original COVID vaccine, Spikevax.

A doctor in a white lab coat shaking hand showing symbol of medicine innovation, treatment, discovery and healthcare analysis. | Image Credit: © chadchai - stock.adobe.com
Geopolitical Shifts Change Nature of Pharma Partnerships

May 28th 2025

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com
FDA Grants Fast Track Designation to Q32 Bio Treatment for Alopecia Areata

April 30th 2025

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com
CHMP Recommends argenx Treatment for Chronic Inflammatory Demyelinating Polyneuropathy

April 28th 2025

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com
FDA Announces New Policy on Advisory Committee Members

April 18th 2025

More News